BRAINSTORM CELL THERAPEUTICS INC·4

Aug 12, 4:43 PM ET

Harel Adrian 4

4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Aug 12, 2011

Insider Transaction Report

Form 4
Period: 2011-06-27
Harel Adrian
Acting Chief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2011-06-27+450,000450,000 total
    Exercise: $0.20From: 2012-01-23Exp: 2021-06-27Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]Option vests and becomes exercisable as to 33.3% of the number of shares subject to the option on January 23, 2012, and the remainder of the shares subject to the option vest and become exercisable in 24 consecutive, equal monthly installments thereafter.

Documents

1 file
  • 4
    v232000_4.xmlPrimary

    OWNERSHIP DOCUMENT